Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,581.00
(
1.15%
)
US TECH 100
23,532.80
(
1.08%
)
Dow Jones
46,208.47
(
1.38%
)
Brent Oil
97.02
(
-10.28%
)
Bitcoin
70,913.95
(
4.53%
)
News Focus
News Focus

Replies to post #182419 on Biotech Values

Replies to #182419 on Biotech Values
icon url

DewDiligence

10/03/14 11:53 AM

#182420 RE: kris_kade #182419

Could be. NVS has a modest-selling HBV drug called Tyzeka/Sebivo, so there would be some synergy from detailing a second HBV drug.